Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study

• Published in: Journal of the American College of Cardiology 2003-06, Vol.41 (11), p.2022-2028
• Main Authors: LIU, Jennifer E, ROBBINS, David C, PALMIERI, Vittorio, BELLA, Jonathan N, ROMAN, Mary J, FABSITZ, Richard, HOWARD, Barbara V, WELTY, Thomas K, LEE, Elisa T, DEVEREUX, Richard B
• Format: Article
• Language: English
• Subjects: Aged; Aging; Albuminuria - physiopathology; Associated diseases and complications; Biological and medical sciences; Cardiology; Cardiovascular disease; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - physiopathology; Diabetes. Impaired glucose tolerance; Diastole - physiology; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Female; Heart Ventricles - physiopathology; Hemodynamics - physiology; Humans; Hypertrophy, Left Ventricular - complications; Hypertrophy, Left Ventricular - physiopathology; Indians, North American; Male; Medical sciences; Middle Aged; Mortality; Multivariate Analysis; Prevalence; Statistics as Topic; Stroke Volume - physiology; Systole - physiology; United States - epidemiology; Ventricular Dysfunction, Left - complications; Ventricular Dysfunction, Left - physiopathology
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/S0735-1097(03)00403-0

We sought to compare systolic and diastolic function in American Indians with diabetes mellitus (DM) based on albuminuria status. Albuminuria has been shown to predict cardiovascular disease (CVD) in populations with DM. However, the mechanism of the association of albuminuria and CVD is unclear. We compared echo-derived indices of left ventricular (LV) systolic and diastolic function in three groups of American Indians with DM based on albuminuria status: I = no albuminuria (300 mg/g). Group II and III were slightly older than Group I with no significant gender difference between groups. Systolic blood pressure increased and body mass index decreased from Group I to Group III. Left ventricular systolic function was lower in the groups with albuminuria with step-wise decreases in ejection fraction and stress-corrected midwall shortening (MWS) from Group I to Group III. Similar findings were noted in diastolic LV filling with lower mitral E/A ratios and longer deceleration times in groups with albuminuria. The proportion of participants with abnormal MWS and abnormal LV diastolic relaxation showed step-wise increases from no albuminuria to macroalbuminuria. In multivariate analysis, albuminuria status remained independently associated with both systolic and diastolic dysfunction after adjusting for age, gender, body mass index, systolic blood pressure, duration of diabetes, coronary artery disease, and LV mass. Albuminuria is independently associated with LV systolic and diastolic dysfunction in type 2 DM; this may explain in part the relationship of albuminuria to increased cardiovascular (CV) events in the DM population. Screening for albuminuria identifies individuals with high CV risk and possible cardiac dysfunction.